Patterson Companies (PDCO)
(Real Time Quote from BATS)
$21.10 USD
-0.83 (-3.79%)
Updated Sep 5, 2024 03:55 PM ET
After-Market: $21.10 0.00 (0.00%) 4:18 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$21.10 USD
-0.83 (-3.79%)
Updated Sep 5, 2024 03:55 PM ET
After-Market: $21.10 0.00 (0.00%) 4:18 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Zacks News
Company News for Dec 3, 2020
by Zacks Equity Research
Companies In The News Are: NTAP, WKHS, AMD, PDCO
Patterson Companies (PDCO) Q2 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal second-quarter 2021 results benefit from strong segmental performance.
Patterson Cos. (PDCO) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 65.79% and 8.81%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?
PDCO vs. MMSI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Is Patterson Companies (PDCO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (PDCO) Outperforming Other Medical Stocks This Year?
Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Patterson Companies' (PDCO) Q2 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.
NextGen (NXGN) Strengthens Portfolio of NextGen Solutions
by Zacks Equity Research
NextGen (NXGN) continues to boost its robust portfolio of NextGen solutions with the latest adoption of NextGen Enterprise by OSMC.
Here's Why You Should Invest in Cardinal Health (CAH) Stock
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.
LHC Group (LHCG) Forays into Oklahoma With New Hospice Buyout
by Zacks Equity Research
LHC Group (LHCG) buys Grace Hospice of Oklahoma to expand its hospice service to Tulsa and throughout the nation.
Here's Why You Should Retain Stryker (SYK) Stock Right Now
by Zacks Equity Research
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
PerkinElmer's Non-Invasive Saliva-Based Testing Gets CE Mark
by Zacks Equity Research
PerkinElmer's (PKI) new saliva-based collection and asymptomatic test solution receives CE-IVD mark.
Here's Why You Should Retain McKesson (MCK) Stock for Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
PDCO vs. COO: Which Stock Is the Better Value Option?
by Zacks Equity Research
PDCO vs. COO: Which Stock Is the Better Value Option?
Has Patterson Companies (PDCO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (PDCO) Outperforming Other Medical Stocks This Year?
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
by Trina Mukherjee
Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.
Patterson Cos. (PDCO) Down 7.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson Cos. (PDCO) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 50.00% and 4.75%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?
Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.
Ciena (CIEN) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ciena's (CIEN) fiscal third-quarter performance is likely to have benefited from the proper execution of its strategy that centers on innovation, diversification and global scale.
What's in Store for Patterson Companies' (PDCO) Q1 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.
Patterson Cos. (PDCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Patterson Cos. (PDCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Fall
by Zacks Equity Research
Barring Respiratory, Gastrointestinal & Renal, Medtronic (MDT) registers dismal performance in all business segments and geographies in Q1.
PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
5 PEG-Driven Value Stocks to Invest in Coronavirus-Hit Market
by Urmimala Biswas
PEG ratio is complicated, considering the limitations in calculating the future earnings growth potential of a stock.